ClinicalTrials.Veeva

Menu

Remote Evaluation of MIND Diet (REMIND)

U

University of Illinois at Urbana-Champaign

Status

Enrolling

Conditions

Cognitive Change
Multiple Sclerosis
Nutrition, Healthy

Treatments

Other: MIND Diet
Other: Control Diet

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The goal of this clinical trial is to learn if increasing adherence to a Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet pattern improves thinking ability and memory compared to a healthy control diet in persons with Multiple Sclerosis (MS). The main question it aims to answer is:

Does the MIND diet improve cognitive performance relative to a control diet in persons with MS?

Participants will:

Consume one meal that follows the MIND diet or a control meal every day for 3 months, complete online surveys and cognitive testing before and after, and keep a record of the food they eat during the study.

Full description

The purpose of this study is to understand how a healthy diet is related to thinking ability and memory in people with multiple sclerosis (MS). This study is fully remote consisting of meals being delivered to participant homes using Daily Harvest meal delivery service. Participants will be asked to consume a microwaveable study meal or prepackaged smoothie every day for 12 weeks. The study meals and smoothies will follow either a dietary pattern thought to improve brain health (Mediterranean-DASH Intervention for Neurodegenerative Delay; MIND), or a control diet, and will include foods commonly found in grocery stores. Participants will not know which diet they are assigned to (active or control). Participants will also be asked to follow simple dietary guidance on a healthy diet in addition to the meals provided. Participants will complete a series of online forms or surveys. Additionally, participants will complete an online cognitive battery from Cambridge Neuropsychological Test Automated Battery (CANTAB) at the beginning and end of the study.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 64 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Individuals aged 18-64 years old
  2. Self-reported diagnosis of Multiple sclerosis (MS)
  3. 20/20 or corrected vision
  4. No other neurodegenerative disease diagnosis
  5. Stable disease-modifying therapy (DMT) within 6 months
  6. Not Pregnant or lactating
  7. No food allergies or intolerances
  8. Able to consume study meals
  9. Not enrolled in another dietary, exercise, or medication study during the study
  10. Access to a computer/laptop with internet

Exclusion criteria

  1. Individuals younger than 18 or older than 64 years old
  2. No self-reported diagnosis of Multiple sclerosis (MS)
  3. Not 20/20 or uncorrected vision
  4. Other neurodegenerative disease diagnosis
  5. Disease modifying therapy (DMT) less than 6 months
  6. Pregnant or lactating
  7. Food allergies or intolerances
  8. Not able to consume study meals
  9. Enrolled in another dietary, exercise, or medication study during the study
  10. No access to a computer/laptop with internet

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

MIND Diet
Experimental group
Description:
Participants in the active MIND diet group will be asked to consume one ready-to-eat meal per day from Daily Harvest® meal delivery service. The treatment meals will follow MIND diet guidelines and include leafy green vegetables, nuts, legumes, whole grains, berries, and extra virgin olive oil.
Treatment:
Other: MIND Diet
Control Diet
Active Comparator group
Description:
Participants in the control diet group will be asked to consume one ready-to-eat meal per day from Daily Harvest® meal delivery service. The Control group will receive daily meals that are isocaloric with the active/experimental meals but will follow a general diet based on the average American diet and Dietary Guidelines for Americans (i.e., vegetables, fruits, nuts, whole grains, and unsaturated fats).
Treatment:
Other: Control Diet

Trial contacts and locations

1

Loading...

Central trial contact

Naiman Khan, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems